Windows 10/8.1 are good operating systems, but not everyone likes the overall design of the Start Menu. Now, there are several options to change the Start Menu to your liking, but today we’re going to ...
Labrys Biologics Secures $31 Million Series A Financing from Venture Capital Firms; Acquires Phase 2 Ready Antibody for Chronic Migraine from Pfizer SAN FRANCISCO, Jan. 3, 2013 /PRNewswire/ -- Labrys ...
Teva Pharmaceuticals will buy San Mateo migraine drug developer Labrys Biologics for as much as $825 million. Teva Pharmaceuticals will buy San Mateo migraine drug developer Labrys Biologics for as ...
JERUSALEM – Teva Pharmaceutical and Labrys Biologics, a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, on Tuesday announced ...
SAN DIEGO & LONDON--(BUSINESS WIRE)--Labrys Technologies, provider of the Axiom remote operations management platform, and Clearspeed, a pioneer in AI-powered voice analytics technology for risk ...
SAN FRANCISCO, March 18, 2013 /PRNewswire/ -- Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced key executive appointments to lead the development of RN-307, ...
Israeli drug giant Teva Pharmaceutical Industries said Tuesday it will shell out up to $825 million for Labrys Biologics, a San Mateo migraine drug developer formed less than two years ago. Teva said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results